Navigation Links
IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
Date:3/27/2008

TORONTO, March 27 /PRNewswire/ - IntelliPharmaCeutics Ltd. (Delaware) is pleased to announce significant results from a recently completed pilot clinical trial for its new abuse-resistant, alcohol-resistant once-a-day oral oxycodone formulation by its operating company IntelliPharmaCeutics Corp. of Toronto ("IntelliPharmaCeutics" or the "Company"). The product is covered by pending patent applications for its novel ReXista(TM) abuse and alcohol resistant drug delivery technology. It is one of the Company's line of in-house analgesic products in development for the management of moderate to severe chronic and acute pain.

The ReXista(TM) oxycodone product is a novel dosage form, designed to be resistant to abuse by oral ingestion when crushed or chewed, by injection when combined with solvents, and by nasal application when crushed or powdered. The abuse of this important pain relief drug has been well documented over many years.

The ReXista(TM) oxycodone product is also designed to resist release of the entire daily dose when consumed with alcohol in any quantity, a problem so serious with some opioid drugs such as hydromorphone that their use has been limited or curtailed by the FDA.

The product has been subjected to rigorous in-vitro testing and has met its design criteria for dissolution profiles and in-vitro resistance to simulated abuse. Based on these initial results, the product is expected to be effective for once-a-day dosing in the management of pain. It is also expected that it will resist abuse by oral, nasal or intravenous administration and resist unintended total dose release in the presence of alcohol.

The initial pilot clinical trial was designed to compare the pharmacokinetic characteristics of the IntelliPharmaCeutics ReXista(TM) oxycodone product, in a once-a-day 40mg dosage format, with a currently marketed branded oxycodone product, Purdue Pharma's Oxycontin(R), in a twice-a-day 20mg dosage format, under fasted
'/>"/>

SOURCE IntelliPharmaCeutics Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...- ImaRx Therapeutics,Inc. ...loping and,commercializing therapies for vascular ...e first quarter ended March 31, 2008 and discussed...ghts:, -- Entered into agreement with Abbott Labo...under non-recourse promissory note issued in conne...
(Date:5/15/2008)...RNewswire/ -- JOM Pharmaceutical Services, Inc.,(J...services and customer,support to Centocor, Inc. an...hat a transport trailer carrying DOXIL(R) (doxorub...alfa) and REMICADE(R) (infliximab) was,stolen whil...ter in,Kentucky to a specialty distributor. This i...
(Date:5/15/2008)...the ,60s cleanup of toxic pollution in Seattle,s ...E, May 15 /- Evolution is supposed to...n the case of a little fish called the,threespine ...peed reverse,according to a study led by research...published online today ahead of print in the May 2...
(Date:5/15/2008)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI),(...he Rodman & Renshaw 5th,Annual Global Healthcare C...lantique Salon, Meridional at the Le Meridien Beac...lso be webcast live with slides, and available,for... accessed at, http://www.celltherapeutics.com ., ...
Breaking Biology Technology:ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 2ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 3ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 4ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 5ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 6ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 7Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product 2Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product 3Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product 4Researchers Document Rapid, Dramatic 'Reverse Evolution' in the Threespine Stickleback Fish 2Researchers Document Rapid, Dramatic 'Reverse Evolution' in the Threespine Stickleback Fish 3Researchers Document Rapid, Dramatic 'Reverse Evolution' in the Threespine Stickleback Fish 4
...ub of Chicago presented its annual outlook for the...Hilton, the guest speakers were Robert J. Dr. Bob ...rray of the Wall Street Journal , and Diane Swonk...lumnist Terry Savage moderated the panel and some .... , , Comparing last year to this year , ,Savage ...
... Miszewski will leave his job as administrator of ...he end of February, about the time an audit on pro...due to be released. , ,Miszewski, who likely will ...ed his staff of the decision in an e-mail and prai... in government. , ,His efforts generally have rec...
...nsin companies raised more venture capital in more...nal in both categories, according to report from ...,Companies in Wisconsin reported 12 venture deals ...leGen Systems , a Madison-based maker of genomic r...total, up from the $55.69 million reported in 2005...
...ilFoundry , a provider of anti-spam appliances and...chnology to combat new spam tactics known as bo...y attacks . , ,The company,s chief executive said ...ts MessageIQ anti-spam engine, defeats botnet spam...ction capabilities. , ,David C. Troup, CEO and fou...
Other Biology Technology:Economic outlook for 2007, and still clueless on Apple 2Economic outlook for 2007, and still clueless on Apple 3Economic outlook for 2007, and still clueless on Apple 4Economic outlook for 2007, and still clueless on Apple 5Miszewski to depart as state IT audit wraps up 2Wisconsin fares slightly better in venture capital chase 2Wisconsin fares slightly better in venture capital chase 3
(Date:5/15/2008)...CAMBRIDGE, Mass.--MIT engineers have improved the ... 50 percent through technology that could help the... find a much broader market, particularly in porta...ork is also considerably less expensive than its c...vantages. , Our goal is to replace traditional f...
(Date:5/15/2008)...LA JOLLA, CA - Now that high school biology studen... transcribed into messenger RNA (mRNA), which is t...ss of molecules, sending studentsand many scientis... Salk Institute for Biological Studies investigato...8 online issue of Developmental Cell, shows that t...
(Date:5/15/2008)...Stowers Institute researchers Karen Staehling-Hamp..., and Olivier Pourqui, Ph.D., Investigator, collab...ow that genes known to cause spinal mutations in c...t role in human patients with congenital vertebral...oday on the Web site of the American Journal of Hu...
(Date:5/15/2008)...Fishermen hold empirical knowledge that tuna aggre...d rope, pieces of wood, or even large marine mamma...gregation behaviour, but the past 20 years have se... the associated concentrations of fish. Fishermen ...act as FADs. An enormous purse-seine net, deployed...
Breaking Biology News(10 mins):MIT creates new material for fuel cells 2MIT creates new material for fuel cells 3Plant biologists discover unexpected proteins affecting small RNAs 2Plant biologists discover unexpected proteins affecting small RNAs 3Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 2Does fishing on drifting fish aggregation devices endanger the survival of tropical tuna? 3Medarex to Present at the 26th Annual JPMorgan Healthcare Conference 2424 1Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals 2421 1Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals 2421 2NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF 03187207 in Japan 1128 1NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF 03187207 in Japan 1128 2NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF 03187207 in Japan 1128 3PolyOne Completes Acquisition of GLS Corporation 9001 1PolyOne Completes Acquisition of GLS Corporation 9001 2PolyOne Completes Acquisition of GLS Corporation 9001 3PolyOne Completes Acquisition of GLS Corporation 9001 4
...new study published in the open-access journal PLo...trophic collapse in orangutan populations living i...ife Sanctuary in Sabah, Malaysia. Benoit Goossens,...leagues report that the collapse occurred within t...past decades--coinciding with massive deforestatio...
...ch year, the red knot, a medium-sized shorebird, m...p of Argentina to the Artic Circle ?one of the lon...ril to June, the red knot stops over in the Delawa...om the largest spawning of horseshoe crabs found o...ers from Virginia Tech and the New Jersey Division...
...new study, to be published in a forthcoming issue ...e prospective gains that could be obtained from fu...rphy and Robert H. Topel, two University of Chicag...nts against major diseases would have a significan...cancer has a value to Americans of nearly $500 bil...
...op yields on farms in developing countries that us...in four years, according to a study scheduled for ...hemical Society journal Environmental Science &a...d to date -- 286 farm projects in 57 countries -- ...e environment in these countries while substantial...
Other Biology News:Genetic study shows humans have pushed orangutans to the brink of extinction 2Horseshoe crab decline threatens shorebird species 2
Anti-HMGN2/HMG-17 Immunogen : Recombinant human HMGN2/HMG-17 Formulation: 0.2M Tris-glycine, pH7.4, 5mg/ml BSA, 0.15M NaCl, 0.05% sodium azide before the addition of glycerol to 30% Quality Assuranc
Luminometers
...man, Assay, 96 wells. ELISA.Specific for total MM...ed MMP-3. No cross-reactivity with MMP-1, -2, -9. ...table for use with cell culture supernatant, serum...t -15 to -30 C. Category: Drug Screening & Cellul...
Dr. P Set from different human fetal normal tissues are available. More organs maybe available upon request. Customers can choose any two items from the whole set, and pay 70% of the whole set pric
Biology Products: